Cetera Investment Advisers
PALI icon

Cetera Investment Advisers’s Palisade Bio PALI Stock Holding History

Cetera Investment Advisers’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4K Buy
15,506
+5,000
+48% +$9.84K ﹤0.01% 4813
2026
Q1 		$18.4K Sell
10,506
-6
-0.1% -$11 ﹤0.01% 4663
2025
Q4 		$24.7K Buy
+10,512
New +$20.2K ﹤0.01% 4565
2025
Q1 		– Sell
-70,006
Closed -$116K – 4046
2024
Q4 		$116K Buy
+70,006
New +$184K ﹤0.01% 3548

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Cetera Investment Advisers's PALI Position: Q2 2026 in Review

Cetera Investment Advisers increased its Palisade Bio (PALI) stake by 48% in Q2 2026, buying an estimated $9.84K and bringing the position to 15,506 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4813.

Cetera Investment Advisers first reported a position in PALI in Q4 2024 and has held it in 4 quarters since. The position peaked at $116K in Q4 2024. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Cetera Investment Advisers held 15,506 shares of Palisade Bio worth $32.4K as of Q2 2026.
  • Cetera Investment Advisers bought 5,000 Palisade Bio shares in Q2 2026, an estimated $9.84K.
  • Palisade Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4813 holding.
  • Cetera Investment Advisers first reported a position in Palisade Bio in Q4 2024 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Palisade Bio position peaked at $116K in Q4 2024.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.